Evidence map›Paper›PMID 41035802›Full record

ArticlePhysics and imaging in radiation oncology2025

Development and characterization of phantoms to investigate the Flash effect with

Riccardo Dal Bello, Marvin Kreuzer, Irene Vetrugno, Jamie C Little, Rafael Kranzer, Stefan Schischke, Lily Bossin, Eduardo Gardenali Yukihara, Matthias Guckenberger, Martin Pruschy and 1 more

Abstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Deciphering Ultra-High Dose Rate Irradiation withAntioxidants (Basel, Switzerland) · 2026
    Article
  2. Development and application ofPhysics and imaging in radiation oncology · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Riccardo Dal BelloDepartment of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Marvin KreuzerLaboratory for Applied Radiobiology, Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Irene VetrugnoDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Jamie C LittleDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
Rafael KranzerPTW-Freiburg, Freiburg im Breisgau, Germany.
Stefan SchischkeRadPro International GmbH, Wermelskirchen, Germany.
Lily BossinDepartment of Radiation Safety and Security, Paul Scherrer Institute, Villigen PSI, Switzerland.
Eduardo Gardenali YukiharaDepartment of Radiation Safety and Security, Paul Scherrer Institute, Villigen PSI, Switzerland.
Matthias GuckenbergerDepartment of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Martin PruschyLaboratory for Applied Radiobiology, Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Stephanie Tanadini-LangDepartment of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Ultra-high dose rate (UHDR) radiotherapy may widen the therapeutic window thanks to the Flash effect. Experimental linear accelerators have been converted to UHDR to collect pre-clinical evidence. Increasing the accessibility, throughput and investigating additional biological endpoints is key for deciphering the mechanism of the Flash effect. The aim of this study was to develop and characterise an experimental platform for UHDR experiments with Materials and methods: A clinical linear accelerator was modified to deliver 16 MeV electron beams in UHDR and conventional (CONV) mode. Two phantoms were developed to irradiate Results: The electron UHDR irradiations provided average dose rates in the range of 200---7500 Gy/s. The beam spatial uniformity within a single vial was better than ± 5 %. The dose delivered to Conclusions: This high-throughput experimental platform on a converted clinical linear accelerator could be used to compare CONV to UHDR for up to 500 animals per week for biological endpoints at up to 1000 Gy. The production of photon megavoltage UHDR radiation was also demonstrated for the first time at a converted clinical linac.

Indexed as

Drosophila melanogasterElectronFlashLinacUltra-high dose rate

Identifiers

PMID41035802
PMCPMC12481075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.